Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02964416 : Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery
PhasePhase 4
AgesMin: 18 Years Max: 65 Years
Eligibility
Inclusion Criteria:

- Patients with craniotomy for supratentorial tumors under general anesthesia

- American Society of Anaesthesiologists (ASA) 2 and stable ASA 3 patients

- Elective surgery

- Patients with Glasgow Coma Scale (GCS) 15/15

Exclusion Criteria:

- Patients with a history of allergy or hypersensitivity to tramadol.

- History of epilepsy or convulsions due to any reason.

- Chronic usage of analgesic drugs.

- Patients using monoamine oxidase inhibitors.

- Patients with clinical signs of raised ICP.

- Obesity (women with a body mass index >35 kg/m2 or men with a body mass index >42
kg/m2)

- Language barrier.

- Patients taking B-blockers or Ca channel blockers.

- Patients above 65 years of age ( Physiology difference)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02964416      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740